The site, at 325 Binney Street, will be designed to be ‘the most sustainable commercial lab building in Cambridge’ targeting LEED Platinum Core & Shell and LEED Zero Energy certifications. The building will have ultra-efficient systems and acoustical and light pollution mitigation measures.
Construction has already begun and a phased move-in process is expected to begin in 2023.
The site will support the company’s growth as it continues to advance its pipeline of mRNA medicines.
“As we advance our mRNA platform and science, our new science center will integrate digital-first scientific research and development labs along with space for innovation and co-creation with our people and our partners around the world,” said Stéphane Bancel, Chief Executive Officer of Moderna.
“Our commitment to sustainability and accessibility requires us to think differently about space.
"Even as we grow, we are committed to minimizing our environmental footprint.
"We will continue to invest in the local economy, work with state and community partners, and leverage the incredible innovation to attract and grow the best talent from the Massachusetts life sciences sector as we work to deliver on the promise of mRNA science.”
The site will be developed by Alexandria Real Estate Equities.
Best known for its COVID-19 vaccine, Moderna has 37 programs in development which includes 22 in clinical studies.
